| CNPEX | MGFLX | CNPEX / MGFLX | |
| Total Expense Ratio | 1.00 | 1.23 | 81% |
| Annual Report Gross Expense Ratio | 1.00 | 1.23 | 81% |
| Fund Existence | 24 years | 21 years | - |
| Gain YTD | 18.969 | 13.389 | 142% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 165B | 155M | 106,452% |
| Annual Yield % from dividends | 0.25 | 0.00 | - |
| Returns for 1 year | 12.64 | -1.63 | -774% |
| Returns for 3 years | 49.24 | -9.67 | -509% |
| Returns for 5 years | 30.57 | -33.94 | -90% |
| Returns for 10 years | 98.74 | -24.35 | -405% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHPAX | 21.77 | 0.01 | +0.05% |
| Saratoga Health & Biotechnology A | |||
| PIREX | 28.15 | -0.32 | -1.12% |
| Principal Real Estate Securities Inst | |||
| OASVX | 12.94 | -0.17 | -1.30% |
| Optimum Small-Mid Cap Value A | |||
| ETLCX | 15.10 | -0.26 | -1.69% |
| Eventide Large Cap Focus C | |||
| GTSDX | 9.40 | -0.40 | -4.08% |
| Invesco Small Cap Growth C | |||